相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Muscarinic Acetylcholine Receptor Agonists as Novel Treatments for Schizophrenia
Steven M. Paul et al.
AMERICAN JOURNAL OF PSYCHIATRY (2022)
Muscarinic Cholinergic Receptor Agonist and Peripheral Antagonist for Schizophrenia
Stephen K. Brannan et al.
NEW ENGLAND JOURNAL OF MEDICINE (2021)
Striatal, Hippocampal, and Cortical Networks Are Differentially Responsive to the M4- and M1-Muscarinic Acetylcholine Receptor Mediated Effects of Xanomeline (vol 10, pg 1753, 2019)
Catherine A. Thorn et al.
ACS CHEMICAL NEUROSCIENCE (2019)
Targeting Muscarinic Acetylcholine Receptors for the Treatment of Psychiatric and Neurological Disorders
Sean P. Moran et al.
TRENDS IN PHARMACOLOGICAL SCIENCES (2019)
Current status of muscarinic M1 and M4 receptors as drug targets for neurodegenerative diseases
Christian C. Felder et al.
NEUROPHARMACOLOGY (2018)
Simplified postoperative nausea and vomiting impact scale for audit and post-discharge review
P. S. Myles et al.
BRITISH JOURNAL OF ANAESTHESIA (2012)
Trospium chloride has no effect on memory testing and is assay undetectable in the central nervous system of older patients with overactive bladder
D. Staskin et al.
INTERNATIONAL JOURNAL OF CLINICAL PRACTICE (2010)
Selective muscarinic receptor agonist xanomeline as a novel treatment approach for schizophrenia
Anantha Shekhar et al.
AMERICAN JOURNAL OF PSYCHIATRY (2008)
A comprehensive approach to the recognition, diagnosis, and severity-based treatment of focal hyperhidrosis: Recommendations of the Canadian Hyperhidrosis Advisory Committee
Nowell Solish et al.
DERMATOLOGIC SURGERY (2007)
Towards a muscarinic hypothesis of schizophrenia
T. J. Raedler et al.
MOLECULAR PSYCHIATRY (2007)
Systematic evaluation of rating scales for impairment and disability in Parkinson's disease
C Ramaker et al.
MOVEMENT DISORDERS (2002)
Therapeutic opportunities for muscarinic receptors in the central nervous system
CC Felder et al.
JOURNAL OF MEDICINAL CHEMISTRY (2000)
分享论文
